The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study

Vibeke Andersen, Lene Agerstjerne, Dorte Jensen, Mette Faurholt Østergaard, Mona Saebø, Julian Hamfjord, Elin Kure, Ulla Birgitte Vogel

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Smoking, dietary factors, and alcohol consumption are known life style factors contributing to gastrointestinal carcinogenesis. Genetic variations in carcinogen handling may affect cancer risk. The multidrug resistance 1(MDR1/ABCB1) gene encodes the transport protein P-glycoprotein (a phase III xenobiotic transporter). P-glycoprotein is present in the intestinal mucosal lining and restricts absorption of certain carcinogens, among these polycyclic aromatic hydrocarbons. Moreover, P-glycoprotein transports various endogenous substrates such as cytokines and chemokines involved in inflammation, and may thereby affect the risk of malignity. Hence, genetic variations that modify the function of P-glycoprotein may be associated with the risk of colorectal cancer (CRC). We have previously found an association between the MDR1 intron 3 G-rs3789243-A polymorphism and the risk of CRC in a Danish study population. The aim of this study was to investigate if this MDR1 polymorphism was associated with risk of colorectal adenoma (CA) and CRC in the Norwegian population.
OriginalsprogEngelsk
Artikelnummer18
TidsskriftB M C Medical Genetics
Vol/bind10
Antal sider6
ISSN1471-2350
DOI
StatusUdgivet - 2009

Fingeraftryk

Dyk ned i forskningsemnerne om 'The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study'. Sammen danner de et unikt fingeraftryk.

Citationsformater